Delayed response and survival from NovoTTF-100A in recurrent GBM

J. Lee Villano, Leena E. Williams, Karriem S. Watson, Nandini Ignatius, Marquess T. Wilson, Tibor Valyi-Nagy, Edward A. Michals, Herbert H. Engelhard

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


We present a 48-year-old male with recurrent glioblastoma (GBM) who was enrolled in the NovoTTF-100A landmark phase III study and has been on device for >6 years. During this time, his magnetic resonance images demonstrated initial growth followed by a slow decrease in enhancement with continued residual disease. Long-term survivors in patients with recurrent GBM are rare, especially in the absence of definitive local treatment such as surgery or radiosurgery. We present the clinical, imaging and pathological findings for this patient in relation to use of the NovoTTF-100A device.

Original languageEnglish
Article number338
JournalMedical Oncology
Issue number1
StatePublished - Mar 2013


  • Brain tumor
  • Glioblastoma
  • Recurrent tumor
  • Survival
  • Tumor treatment fields

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research


Dive into the research topics of 'Delayed response and survival from NovoTTF-100A in recurrent GBM'. Together they form a unique fingerprint.

Cite this